Andreoli, M. T.; Pinnolis, M.; Kieser, T.; Sun, J.; Andreoli, C. M. Feasibility and Efficacy of a Mass Switch from Ranibizumab (Lucentis) to Bevacizumab (Avastin) for Treatment of Neovascular Age-Related Macular Degeneration. Digit J Ophthalmol 2015, 21, 29-34.